glp-1 new hope Exciting research: meds show promise for cancer patients! Potential to slow progression and boost survival rates. A hope? #GLP1 #CancerResearch #MedicalBreakthrough #Oncology #PatientCare NEW HOPE WEIGHT LOSS -

Featuring Akkermansia, a novel gut strain, the formula is marketed to support blood sugar and metabolism

Each serving delivers 78 billion CFUs from a broad range of beneficial strains including Lactobacillus, Bifidobacterium, Akkermansia muciniphila and Christensenella minuta, known for their contribution to a balanced gut microbiome

GLP-1 receptor (GLP-1R) agonists, like liraglutide, have shown analgesic effects by modulating pain hypersensitivity in animal models of inflammatory and neuropathic pain

Bitter Melon helps support metabolism, while Citrus Bergamot and Fenugreek contribute to lipid metabolism and digestive comfort

Has the finished Multi+ formula been clinically studied

RYGB produces higher early postprandial increases in GLP-1 and glucose than OAGB, demonstrating that procedural differences can influence gut hormone and glucose responses.